The Lancet Infectious Diseases
Journal providing information about infectious diseases.
The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.
The Lancet Infectious Diseases has an Impact Factor of 27·516® and ranks first among infectious diseases journals (2018 Journal Citation Reports®, Clarivate Analytics 2019). The Lancet Infectious Diseases is recognised for providing a global, authoritative, and independent forum for the highest quality infectious diseases research and opinion, covering such areas as the treatment and research of HIV/AIDS, antibiotic resistance, emerging infections, and public health.
Visit website: https://www.thelancet.com/laninf/about
See also: 
The Lancet
- Medical journal covering general medicine
Details last updated 23-Nov-2019
The Lancet Infectious Diseases News
Diabetes medication metformin could lower long COVID risk by 41%, study suggests
New Scientist - 09-Jun-2023
Metformin may function as an anti-inflammatory and potentially reduce the viral load of SARS-CoV-2
Read more...New antibiotic appears promising in early clinical trials
BBC - 26-Oct-2018
Superbugs are on the rise and we are running out of time
Read more...World on cusp of ‘post-antibiotic era’
BBC - 19-Nov-2015
Common infections would kill once again, surgery and cancer therapies under threat. Bacteria fou...
Read more...
